ALEXIS GILL: Open Payments
NPI 1477232437 · FERNANDINA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| REVANCE THERAPEUTICS, INC. | 1 | $37 |
| Radius Health, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: MOUNJARO, TRELEGY ELLIPTA, Kerendia, DAXXIFY, GVOKE HYPOPEN, Rybelsus, XIFAXAN, GEMTESA.
Industry payments across FL — which companies pay providers there.
